Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 21,011

Document Document Title
WO/2020/102576A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2020/102574A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: Formula AA or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2020/094542A1
The invention relates to 5,6-diphenyl-5,6-dihydro- dibenz[c,e][1,2 ]azaphosphorin and 6-phenyl-6H-dibenzo[c,e] [1,2]thiazin-5,5 dioxide derivatives and similar compounds of the formula (1) as organic electroluminescent materials for use ...  
WO/2020/095983A1
It was discovered that a cyclic sulfamidate could be produced by reacting an aminoacid derivative with a cyclization reagent. In addition, it was discovered that an O-substituted serine derivative could be produced by reacting the cyclic...  
WO/2020/096001A1
A compound represented by formula (1) (wherein R1 to R8, R10 to R19, R30 to R46, Ar, L, and *a are as defined in the description) is useful in providing an organic EL element having improved element performance.  
WO/2020/093286A1
A non-fused electron acceptor material, a preparation method and an organic solar cell constructed using same. The organic solar cell comprises a substrate, a negative electrode, an electron transport layer, an active layer, a positive e...  
WO/2020/095031A1
Organosulfur compounds of formula (I), where R1 and R2 are as defined herein, and pharmaceutical compositions comprising these organosulfur compounds. Uses of the organosulfur compounds and the pharmaceutical compositions for treating in...  
WO/2020/090843A1
A charge transport material which is represented by general formula (1). In the formula, one of R1-R5 moieties represents a cyano group, while two to four of the R1-R5 moieties represent a group represented by general formula (2); X repr...  
WO/2020/091446A1
The present disclosure relates to an organic electroluminescent compound and an organic electroluminescent device comprising the same. By comprising the organic electroluminescent compound according to the present disclosure, an organic ...  
WO/2020/087233A1
Disclosed is an application of an ionic iron (III) complex as a catalyst in preparation of a benzylamine compound, that is, an ionic iron (III) complex having a molecular formula of [(RNCHCHNR)CH][FeBr4] (R is tert-butyl) and containing ...  
WO/2020/089138A1
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, to a process for manufacturing the compounds of formula (1), to intermediat...  
WO/2020/092239A1
Provided herein are processes for the preparation of N1,N3-dialkylated thienopyrimidinediones that are useful as fungicides, and related precursors and intermediates.  
WO/2020/085396A1
A cross-coupling reaction method including: preparation of an aromatic compound (1) that has a leaving group; preparation of a compound (2) capable of a cross-coupling reaction, the compound (2) being selected from aromatic amino compoun...  
WO/2020/086728A1
In one aspect, compounds of Formula A, or a pharmaceutically acceptable salt thereof, are featured (Formula A) or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2020/085797A1
The present invention relates to a compound for an organic electric element, an organic electric element using same, and an electronic device thereof. According to the present invention, high light-emitting efficiency, low driving voltag...  
WO/2020/084094A1
The present invention relates to a process for preparing a nitrated compound, comprising the step of reacting a compound (A) comprising at least one substituted or unsubstituted aromatic or heteroaromatic ring, wherein said heteroaromati...  
WO/2020/083327A1
Disclosed in the present invention is an organic compound containing a spirobifluorene structure, having a structure as represented by chemical formula (1), wherein Ar1(Ar2)N-(S1)m- and -(S2)n-NAr3(Ar4) are different, and have symmetrica...  
WO/2020/086732A1
In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.  
WO/2020/082817A1
The present application pertains to the technical field of pharmaceutical compounds and drugs, relates to an oxime-based naphthoquinone compound, a preparation method therefor and the uses thereof, and specifically relates to a formula (...  
WO/2020/078368A1
An organic phosphorus compound, a preparation method therefor, and the uses thereof. The organic phosphorus compound exhibits significant bearing capacity, and excellent antiwear and wear reduction properties, while being an EP antiwear ...  
WO/2020/081446A1
Embodiments are directed to a series of novel small molecule activators of NRF2 dependent gene expression that are evaluated in an effort to develop therapeutic methods against diseases with deregulated KEAP1-NRF2 signaling.  
WO/2020/080979A1
This disclosure relates to new phthalimide and isoindolinone derivatives and other PFKFB3 inhibitors for use in the treatment of diseases. The invention further relates to pharmaceutical compositions containing such PFKFB3 inhibitors, me...  
WO/2020/076035A1
The present invention provides a thiophene carboxamide compound of the following general formula (I), which is a novel fluorine-substituted biphenyl carboxamide-based compound, and provides a useful compound, as an agricultural and horti...  
WO/2020/075964A1
The present invention provides a novel compound and an organic light emitting diode using same.  
WO/2020/073031A1
This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases related to nicotinamide phosphoribosyltransferase (NAM FT) expression. More part...  
WO/2020/071550A1
The present invention provides a novel CDK8 inhibitor. The present invention relates to: a compound represented by general formula (I) (wherein the symbols are as defined in the description) or a pharmaceutically acceptable salt thereof;...  
WO/2020/065642A1
The present invention provides new GABAA receptor-binding compounds that modify the activation of GABAA, their use in in the preparation of a neuroactive pharmaceutical composition, improving sperm motility and labeling of biomolecules.  
WO/2020/065119A1
The invention relates to a group of compounds with a structural nucleus of acylhydrazone, which are capable of modulating the interaction between the proteins NCS-1 and Ric8a involved in the process of regulating the number of synapses a...  
WO/2020/054420A1
A fluorine-containing ether compound represented by formula (1) (1: R1-R2-CH2-R3-CH2-R4) (In formula (1), R1 is represented by formula (2), R2 is represented by formula (3), R3 is a perfluoropolyether chain, and R4 is an organic end grou...  
WO/2020/055883A1
The present disclosure provides certain 2,3-dihydrobenzo[b]thiophene compounds that are Hypoxia Inducible Factor 2α (HIF-2α) inhibitors and are therefore useful for the treatment of diseases treatable by inhibition of HIF-2α. Also pro...  
WO/2020/047668A1
Provided herein are Myc-Max inhibitory compounds having the structure of Formula (I) and compositions thereof for use in the treatment of cancer. In particular, the Myc-Max inhibitory compounds may be useful for the treatment of cancers ...  
WO/2020/050368A1
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...  
WO/2020/045597A1
Provided is a novel chalcogen-containing organic semiconductor compound having excellent carrier mobility. The compound is represented by formula (1a) or (1b). (In formulae (1a) and (1b), X represents S, O, or Se and R1's each independen...  
WO/2020/042903A1
The present invention provides a maleate, phosphate, sulfate, and hydrochloride of a cyclohexane derivative, N'-[trans-4-[2-[7-(benzo[b]thiophene)-7-piperazinyl]ethyl]cy clohexyl]-N,N-dimethylurea, as shown in formula I and crystal forms...  
WO/2020/046975A1
Described herein are methods of treating or preventing an ASK1 or DYRK1A associated disease, disorder, or condition comprising administering to a subject in need thereof a dual inhibitor of ASK1 and DYRK1A; including administering pharma...  
WO/2020/040233A1
The present invention provides a method for obtaining a specifically-shaped crystal (specifically, spherocrystal) of a compound with good reproducibility. This method for producing a specifically-shaped crystal (specifically spherocrysta...  
WO/2020/034945A1
The present invention provides a method for preparing a cyclohexane derivative, comprising the following steps: (1) subjecting a compound SM01 and a compound SM02 or a salt thereof to a nucleophilic substitution reaction to obtain a comp...  
WO/2020/034946A1
Provided is a method for preparing a cyclohexane derivative, the method comprising the following steps: subjecting a compound, 2-(4-(3,3-dimethylureido)cyclohexyl)acetaldehyde, represented by formula SM01 and a compound represented by fo...  
WO/2020/036069A1
Provided are: a composition for forming a hole transporting layer for perovskite solar cells, which is inexpensive and does not need to be used together with a dopant; and a compound which can be contained in a composition for forming a ...  
WO/2020/037251A1
This invention is a benzothiophene estrogen receptor modulator or its pharmaceutically acceptable salt, N-oxide, isotopic derivative or prodrug thereof or a pharmaceutically acceptable composition thereof to treat an estrogen-related med...  
WO/2020/033782A1
The present invention is directed to compounds of Formula (I), which are activators of the RIG-I pathway.  
WO/2020/027150A1
A compound represented by general formula (I) (wherein each symbol is as defined in the description) or a salt thereof has a potent neural protecting and/or repairing effect and, therefore, is usable as a therapeutic agent for neurologic...  
WO/2020/022779A1
The present invention provides a novel heterocyclic compound and an organic light-emitting device using same.  
WO/2020/021021A1
The present invention relates to ortho substituted phenoxypropylamino and benzyloxypropylamino derivatives having pharmacological activity towards the α2δ subunit of the voltage-gated calcium channel, in particular to ortho substituted...  
WO/2020/012403A1
The present invention relates to an improved process for diastereoselective synthesis of vicinal diamines (1). The process involves highly regio- and diastereoselective addition of 2-azaallyl anions (4) to N-tert-butanesulfinylimines (5)...  
WO/2020/013696A1
The present invention pertains to novel thiocycloheptyne derivatives of general formula (I) : and in particular to thiacycloalkynesulfoimine derivatives and their synthesis. The invention also relates to the use of the novel thiocyclohep...  
WO/2020/013572A1
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/013574A1
The present specification provides a compound of chemical formula 1 and an organic light emitting diode comprising same.  
WO/2020/011935A1
The invention relates to a new alkinylating and cyanating agent of the formula (I) or (II), and to the preparation and use thereof, for introducing nitrile(cyan) groups or alkyne groups into chemical target molecules by way of electrophi...  
WO/2020/007905A1
The present disclosure relates to thienyloxazolones and analogues thereof of formula (III) that may be used for protecting plants from bacterial diseases, in particular from bacterial diseases caused by bacteria belonging to the genus Xa...  

Matches 1 - 50 out of 21,011